acc2551 |
AKT |
phosphorylation |
Thr308 |
human |
Neuroblastoma |
SK-N-SH neuroblastoma cells |
Rapamycin |
Enhancing |
4.0 (Moderate) |
23127854
|
acc2552 |
AKT |
phosphorylation |
Ser473 |
human |
Neuroblastoma |
SK-N-SH neuroblastoma cells |
Okadaic acid |
Enhancing |
4.0 (Moderate) |
23127854
|
acc2553 |
AKT |
phosphorylation |
Ser473 |
human |
Neuroblastoma |
SK-N-SH neuroblastoma cells |
Rapamycin |
Enhancing |
4.0 (Moderate) |
23127854
|
acc2554 |
PKCzeta |
ubiquitination |
Lys48 |
human |
Lung Cancer |
|
HOIL-1L expression |
Enhancing |
3.0 (Low)
|
25118570
|
acc2555 |
VASP |
phosphorylation |
Ser239 |
human |
Lung Cancer |
|
Baicalein |
Enhancing |
4.0 (Moderate) |
25268843
|
acc2556 |
AKT |
phosphorylation |
Ser473 |
human |
Myeloma |
|
Ritonavir |
Associated |
4.0 (Moderate) |
25542900
|
acc2557 |
AKT |
phosphorylation |
Ser473 |
human |
Myeloma |
|
Metformin |
Impairing |
5.0 (High)
|
25542900
|
acc2558 |
mTORC1 |
phosphorylation |
Thr172 |
human |
Myeloma |
|
Ritonavir |
Associated |
4.0 (Moderate) |
25542900
|
acc2559 |
mTORC1 |
phosphorylation |
Thr172 |
human |
Myeloma |
|
Metformin |
Impairing |
5.0 (High)
|
25542900
|
acc2560 |
Trx1 |
oxidation |
unclear |
human |
Breast Cancer |
MDA-MB-231 |
2DG + Au |
Enhancing |
5.0 (High)
|
25560241
|
acc2561 |
Trx1 |
oxidation |
unclear |
human |
Breast Cancer |
MDA-MB-231 |
2DG + DHEA |
Enhancing |
5.0 (High)
|
25560241
|
acc2562 |
Trx1 |
oxidation |
unclear |
human |
Prostate Cancer |
PC3 |
2DG + Au |
Enhancing |
5.0 (High)
|
25560241
|
acc2563 |
Trx1 |
oxidation |
unclear |
human |
Prostate Cancer |
PC3 |
2DG + DHEA |
Enhancing |
5.0 (High)
|
25560241
|
acc2564 |
Trx1 |
oxidation |
unclear |
human |
Prostate Cancer |
DU145 |
2DG + Au |
Enhancing |
5.0 (High)
|
25560241
|
acc2565 |
Trx1 |
oxidation |
unclear |
human |
Prostate Cancer |
DU145 |
2DG + DHEA |
Enhancing |
5.0 (High)
|
25560241
|
acc2566 |
Trx1 |
oxidation |
Cys62 |
human |
Neuroblastoma |
SH-SH5Y |
As(2-mercaptopyridine)3 |
Enhancing |
4.0 (Moderate) |
26169724
|
acc2567 |
Trx1 |
oxidation |
Cys69 |
human |
Neuroblastoma |
SH-SH5Y |
As(2-mercaptopyridine)3 |
Enhancing |
4.0 (Moderate) |
26169724
|
acc2568 |
Trx1 |
oxidation |
Cys62 |
human |
Neuroblastoma |
SH-SH5Y |
As(2-mercaptopyridine N-oxide)3 |
Enhancing |
4.0 (Moderate) |
26169724
|
acc2569 |
Trx1 |
oxidation |
Cys69 |
human |
Neuroblastoma |
SH-SH5Y |
As(2-mercaptopyridine N-oxide)3 |
Enhancing |
4.0 (Moderate) |
26169724
|
acc2570 |
PKM2 |
glycosylation |
Arg399 |
human |
Cancer |
|
MG |
Impairing |
5.0 (High)
|
26911935
|
acc2571 |
AKT |
phosphorylation |
Ser473 |
human |
Leukemia |
|
Sanguinarine |
Associated |
4.0 (Moderate) |
27154977
|
acc2572 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
SKOV3 |
Delphinidin |
Impairing |
4.0 (Moderate) |
29122484
|
acc2573 |
Smad3 |
phosphorylation |
Thr179 |
human |
Hepatocellular Carcinoma |
|
TGF-beta |
Impairing |
4.5 (High)
|
29524413
|
acc2574 |
ERK1 |
phosphorylation |
Thr202 |
human |
Ovarian Cancer |
|
PD98049 |
Enhancing |
5.0 (High)
|
29693189
|
acc2575 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Ovarian Cancer |
|
PD98049 |
Enhancing |
5.0 (High)
|
29693189
|
acc2576 |
ERK2 |
phosphorylation |
Thr185 |
human |
Ovarian Cancer |
|
PD98049 |
Enhancing |
5.0 (High)
|
29693189
|
acc2577 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Ovarian Cancer |
|
PD98049 |
Enhancing |
5.0 (High)
|
29693189
|
acc2578 |
AKT |
phosphorylation |
Ser473 |
human |
Cervical Cancer |
C33A |
Emodin |
Associated |
4.0 (Moderate) |
30057674
|
acc2579 |
AKT |
phosphorylation |
Ser473 |
human |
Oral Cancer |
HSC-3 |
Emodin |
Associated |
4.0 (Moderate) |
30057674
|
acc2580 |
eIF2alpha |
phosphorylation |
Ser51 |
human |
Prostate Cancer |
DU145 |
Boric acid |
Associated |
4.0 (Moderate) |
30196486
|
acc2581 |
c-Jun |
phosphorylation |
Ser63 |
human |
Pancreas Cancer |
PANC-1 |
ActD |
Enhancing |
5.0 (High)
|
30295945
|
acc2582 |
AKT |
phosphorylation |
Ser473 |
human |
Gastric Cancer |
HGC-27 |
Aloin |
Associated |
4.0 (Moderate) |
32021099
|
acc2583 |
AKT |
phosphorylation |
Ser473 |
human |
Gastric Cancer |
BGC-823 |
Aloin |
Associated |
4.0 (Moderate) |
32021099
|
acc2584 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Gastric Cancer |
HGC-27 |
Aloin |
Associated |
4.0 (Moderate) |
32021099
|
acc2585 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Gastric Cancer |
BGC-823 |
Aloin |
Associated |
4.0 (Moderate) |
32021099
|
acc2586 |
IkappaBalpha |
phosphorylation |
Ser32 |
human |
Gastric Cancer |
HGC-27 |
Aloin |
Associated |
4.0 (Moderate) |
32021099
|
acc2587 |
IkappaBalpha |
phosphorylation |
Ser32 |
human |
Gastric Cancer |
BGC-823 |
Aloin |
Associated |
4.0 (Moderate) |
32021099
|
acc2588 |
mTOR |
phosphorylation |
Ser2448 |
human |
Gastric Cancer |
HGC-27 |
Aloin |
Associated |
4.0 (Moderate) |
32021099
|
acc2589 |
mTOR |
phosphorylation |
Ser2448 |
human |
Gastric Cancer |
BGC-823 |
Aloin |
Associated |
4.0 (Moderate) |
32021099
|
acc2590 |
Akt |
phosphorylation |
Ser473 |
mouse |
Breast Cancer |
4T1 |
Doxorubicin |
Impairing |
5.0 (High)
|
32035191
|
acc2591 |
eIF2alpha |
phosphorylation |
Ser51 |
human |
Breast Cancer |
T47D |
Lapatinib |
Enhancing |
5.0 (High)
|
32365111
|
acc2592 |
eIF2alpha |
phosphorylation |
Ser51 |
human |
Breast Cancer |
MCF7 |
Lapatinib |
Enhancing |
5.0 (High)
|
32365111
|
acc2593 |
AMPK |
phosphorylation |
Thr183 |
human |
Lung Cancer |
A549 |
"cis,cis,trans-[Pt(NH3)2Cl2(BEZ)(OH)] (CB)" |
Impairing |
5.0 (High)
|
34388483
|
acc2594 |
AMPK |
phosphorylation |
Thr172 |
human |
Lung Cancer |
A549 |
"cis,cis,trans-[Pt(NH3)2Cl2(BEZ)2] (CP)" |
Impairing |
5.0 (High)
|
34388483
|
acc2595 |
CDKN1B |
phosphorylation |
unclear |
human |
Breast Cancer |
|
NP-ALT |
Associated |
4.0 (Moderate) |
34446542
|
acc2596 |
RNF4 |
methylation |
Arg164 |
human |
Leukemia |
|
As2O3 |
Impairing |
5.0 (High)
|
35622143
|
acc2597 |
ASK1 |
phosphorylation |
Ser967 |
human |
Ovarian Cancer |
SKOV3 |
PUMA OE + paclitaxel |
Associated |
4.0 (Moderate) |
36122664
|
acc2598 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Ovarian Cancer |
SKOV3 |
PUMA OE + paclitaxel |
Associated |
4.0 (Moderate) |
36122664
|
acc2599 |
BCL-XL |
phosphorylation |
Ser62 |
human |
Ovarian Cancer |
SKOV3 |
PUMA OE + paclitaxel |
Associated |
4.0 (Moderate) |
36122664
|
acc2600 |
PP2A |
methylation |
unclear |
human |
Glioblastoma |
U87-MG |
Radiotherapy |
Enhancing |
4.5 (High)
|
37500619
|